Control group | Group 1: mild disease | Group 2: moderate disease | Group 3: severe disease | Significance among all groups | ||
Months from PCR (mean, SD) | – | – | 8.20 (0.62) | 8.74 (0.68) | ||
Gender (n, %) | Male | 8 (42.10) | 6 (33.33) | 9 (42.85) | 9 (52.94) | 0.711* |
Female | 11 (57.89) | 12 (66.66) | 12 (57.14) | 8 (47.05) | ||
Age (years, SD) | 38, 79 (8, 15) | 40, 61 (11, 04) | 43, 29 (8, 49) | 46, 00 (5, 75) | 0.078+ | |
Race (n) | Caucasian | 19 | 17 | 15 | 9 | 0.008* |
Latin | 0 | 1 | 6 | 7 | ||
Other | 0 | 0 | 0 | 1 | ||
Diabetes (n) | No | 19 | 18 | 20 | 15 | 0.236* |
Yes | 0 | 0 | 1 | 2 | ||
Smoker (n) | No | 16 | 15 | 21 | 15 | 0.292* |
Yes | 3 | 3 | 0 | 2 |
Significant values shown in bold.
*Χ2 test.
†ANOVA test.
ANOVA, analysis of variance.